Recently, investment firm B. Riley downgraded its rating on Centessa Pharmaceuticals plc (stock code: CNTA) from "Buy" to "Neutral".

老虎证券2026/03/31 14:09

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Meanwhile, the institution raised its target share price from $42 to $45. This rating adjustment reflects analysts' reassessment of the company's current valuation and future development potential. While the increase in target price indicates recognition of long-term value, the downgrade suggests that, in the short term, the share price may have already approached a reasonable range.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Recently, investment firm B. Riley downgraded its rating on Centessa Pharmaceuticals plc (stock code: CNTA) from "Buy" to "Neutral".

You may also like

Crypto prices